Rroji, M.; Spahia, N.; Figurek, A.; Spasovski, G.
Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. Biomedicines 2025, 13, 728.
https://doi.org/10.3390/biomedicines13030728
AMA Style
Rroji M, Spahia N, Figurek A, Spasovski G.
Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. Biomedicines. 2025; 13(3):728.
https://doi.org/10.3390/biomedicines13030728
Chicago/Turabian Style
Rroji, Merita, Nereida Spahia, Andreja Figurek, and Goce Spasovski.
2025. "Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation" Biomedicines 13, no. 3: 728.
https://doi.org/10.3390/biomedicines13030728
APA Style
Rroji, M., Spahia, N., Figurek, A., & Spasovski, G.
(2025). Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. Biomedicines, 13(3), 728.
https://doi.org/10.3390/biomedicines13030728